Valeant Providing Reporters With an Earnings Metric the SEC Ordered it to Stop Using Post author:Sam Post published:November 9, 2017 Post category:BioPharma Valeant is not the only company to recently push reporters to defy the SEC’s orders. Source: BioSpace You Might Also Like FUJIFILM Release: FDA Approves The Company's Digital Breast Tomosynthesis Option For ASPIRE Cristalle Digital Mammography System January 23, 2017 How Immigration Ban is Already Hurting Science January 29, 2017 MedicalSystem Biotechnology to Sell 49 PCT Stake in Hong Kong-based Unit for HK$ 90.7 Million August 3, 2017
FUJIFILM Release: FDA Approves The Company's Digital Breast Tomosynthesis Option For ASPIRE Cristalle Digital Mammography System January 23, 2017
MedicalSystem Biotechnology to Sell 49 PCT Stake in Hong Kong-based Unit for HK$ 90.7 Million August 3, 2017
